[The characteristics of Alzheimer's Disease Units in relation to neuropsychological tests]

Ann Ist Super Sanita. 2005;41(1):63-8.
[Article in Italian]

Abstract

The Cronos Project is a post-marketing surveillance study implemented by the Italian Ministry of Health and the National Institute of Health whose main objectives are to characterise the population of Alzheimer's disease patients treated with acetylcholinesterase inhibitors and monitor effectiveness and drug safety in the field practice. In this project 503 Alzheimer's disease units were activated located throughout the country. The characteristics of these Alzheimer's disease units are presented for setting (territorial, university, hospital, extra-hospital), health personnel employed, examinations offered (CT and MRI scans and laboratory tests), counselling activities and relationship with caregiver associations in relation to neuropsychological tests.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / psychology*
  • Alzheimer Disease / rehabilitation
  • Caregivers / psychology
  • Cholinesterase Inhibitors / therapeutic use
  • Counseling / organization & administration
  • Counseling / statistics & numerical data
  • Diagnostic Imaging / statistics & numerical data
  • Health Personnel
  • Hospital Units / organization & administration
  • Hospital Units / statistics & numerical data*
  • Hospitals, University / organization & administration
  • Hospitals, University / statistics & numerical data
  • Humans
  • Italy
  • Neurology
  • Neuropsychological Tests*
  • Nootropic Agents / therapeutic use
  • Patient Education as Topic / statistics & numerical data
  • Product Surveillance, Postmarketing*
  • Psychology
  • Research / statistics & numerical data
  • Residential Facilities / organization & administration
  • Residential Facilities / statistics & numerical data*
  • Self-Help Groups / organization & administration
  • Treatment Outcome

Substances

  • Cholinesterase Inhibitors
  • Nootropic Agents